NCT04866706View on ClinicalTrials.gov

Performance and Safety of Routine Cataract Surgery With Visiol

CompletedOBSERVATIONAL
Enrollment

100

Participants

Timeline

Start Date

January 27, 2022

Primary Completion Date

December 9, 2022

Study Completion Date

October 27, 2023

Conditions
Following Cataract Surgery
Interventions
DEVICE

Visiol

VISIOL is a 2.0% (m/v) SH viscoelastic solution used for ocular surgery.

Trial Locations (1)

10400

Rajavithi Hospital, Bangkok

All Listed Sponsors
lead

TRB Chemedica

INDUSTRY